Skip to content

RGC REGENCELL BIOSCIENCE HLDGS L

Follow

Stock (common), issuer CIK 1829667

6 managers (6 13F filers) reported a position in RGC shares at 2025-03-31, 8,830 shares in all. 3 filers opened a position and 1 filer sold out during the quarter.

Managers
6
13F filers
6
New
3
Added
1
Reduced
1
Sold out
1
Shares held by filers
8,830

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2025

Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
GEODE CAPITAL MANAGEMENT, LLCin group GEODE CAPITAL MANAGEMENT, LLC6,816$217K<0.01%new13F-HRTimelineGroup
ROYAL BANK OF CANADAin group ROYAL BANK OF CANADA948$30K<0.01%new13F-HR/ATimelineGroup
Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T…698$22.3K<0.01%new13F-HRTimelineGroup
BlackRock, Inc.in group BlackRock, Inc.363$11.6K<0.01%+12513F-HRTimelineGroup
MORGAN STANLEYin group MORGAN STANLEY5$159<0.01%-2,09513F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$0013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.